PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 178 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $62,066,000 | +7.8% | 1,921,554 | +14.2% | 0.01% | -8.3% |
Q3 2016 | $57,571,000 | +7.2% | 1,682,381 | +5.7% | 0.01% | 0.0% |
Q2 2016 | $53,688,000 | -36.0% | 1,591,688 | +0.6% | 0.01% | -36.8% |
Q1 2016 | $83,827,000 | -30.2% | 1,582,234 | +1.2% | 0.02% | -32.1% |
Q4 2015 | $120,108,000 | +76.2% | 1,564,114 | -5.7% | 0.03% | +55.6% |
Q3 2015 | $68,185,000 | -40.8% | 1,658,993 | +1.8% | 0.02% | -35.7% |
Q2 2015 | $115,216,000 | -19.4% | 1,629,188 | +1.3% | 0.03% | -17.6% |
Q1 2015 | $142,946,000 | +5.7% | 1,608,851 | +5.5% | 0.03% | +3.0% |
Q4 2014 | $135,242,000 | +1.2% | 1,525,402 | +10.6% | 0.03% | -13.2% |
Q3 2014 | $133,699,000 | +7.5% | 1,379,476 | +1.8% | 0.04% | +8.6% |
Q2 2014 | $124,427,000 | +43.8% | 1,354,524 | +9.5% | 0.04% | +34.6% |
Q1 2014 | $86,552,000 | +24.8% | 1,236,636 | +2.5% | 0.03% | +23.8% |
Q4 2013 | $69,359,000 | +19.9% | 1,206,457 | +0.3% | 0.02% | +5.0% |
Q3 2013 | $57,845,000 | +88.0% | 1,203,222 | +13.4% | 0.02% | +81.8% |
Q2 2013 | $30,775,000 | – | 1,061,198 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |